Download PDF
Thromb Haemost 1995; 74(01): 111-116
DOI: 10.1055/s-0038-1642662
Symposium
Platelet Activation and Signal Transduction
Schattauer GmbH Stuttgart

Platelet Activation: Signal Transduction Via Membrane Receptors

Kenneth J Clemetson
Theodor Kocher Institute, University of Berne, Berne, Switzerland
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Kroll MH, Heliums JD, Guo Z, Durante W, Razdan K, Hrbolich JK, Schafer AI. Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem 1993; 268: 3520-3524
    PubMedGoogle Scholar
  • 2 Miller JL, Cunningham D, Lyle VA, Finch CN. Mutation in the gene encoding the a-chain of platelet glycoprotein lb in platelet-type von Willebrand disease. Proc Natl Acad Sci USA 1991; 88: 4761-4765
    CrossrefPubMedGoogle Scholar
  • 3 Randi AM, Rabinowitz I, Mancuso DJ, Mannucci PM, Sadler JE. Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein lb binding sequences J Clin Invest 1991; 87: 1220-1226
    CrossrefPubMedGoogle Scholar
  • 4 Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein l b. Thromb Haemost 1990; 64: 326-332
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Sugimoto M, Mohri H, McQintock RA, Ruggeri ZM. Identification of discontinous von Willebrand factor sequences involved in complex formation with botrocetin. J Biol Chem 1991; 266: 18172-18178
    PubMedGoogle Scholar
  • 6 Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI. Von Willebrand factor binding to platelet Gplb initiates signals forplatelet activation. J Clin Invest 1991; 88: 1568-1573
    CrossrefPubMedGoogle Scholar
  • 7 Razdan K, Heliums JD, Kroll MH. Shear-stress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinase(s). Biochem J 1994; 302: 681-686
    CrossrefPubMedGoogle Scholar
  • 8 Jackson SP, Schoenwaelder SM, Yuan Y, Rabinowitz I, Salem HH, Mitchell CA. Adhesion receptor activation of phosphatidylinositol 3-kinase, von Willebrand factor stimulates the cytoskeletal association and activation of phosphatidylinositol 3-kinase and pp60c-src in human platelets. J Biol Chem 1994; 269: 27093-9
    PubMedGoogle Scholar
  • 9 Andrews RK, Fox JE B. Interaction of purified actin-binding protein with the platelet membrane glycoprotein Ib-IX complex. J Biol Chem 1991; 266: 7144-7147
    PubMedGoogle Scholar
  • 10 Fox JE, Bemdt MC. Cyclic AMP-dependent phosphorylation of glycoprotein lb inhibits collagen-induced polymerization of actin in platelets. J Biol Chem 1989; 264: 9520-9526
    PubMedGoogle Scholar
  • 11 Michelson AD, Ellis PA, Barnard MR, Matic GB, Viles AF, Kestin AS. Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosine diphosphate, or an in vivo wound. Blood 1991; 77: 770-9
    PubMedGoogle Scholar
  • 12 White JG, Burris SM, Hasegawa D, Johnson M. Micropipette aspiration of human blood platelets: a defect in Bemard-Soulier’s syndrome. Blood 1984; 63: 1249-1252
    PubMedGoogle Scholar
  • 13 McNicol A, Drouin J, Clemetson KJ, Gerrard JM. Phospholipase C activity in platelets from Bemard-Soulier syndrome patients. Arterioscler Thromb 1993; 13: 1567-1571
    CrossrefPubMedGoogle Scholar
  • 14 Du X, Harris SJ, Tetaz TJ, Ginsberg MH, Bemdt MC. Association of a phospholipase A2 (14-3-3 protein) with the platelet glycoprotein Ib-IX complex. J Biol Chem 1994; 269: 18287-18290
    PubMedGoogle Scholar
  • 15 Chediak J, Telfer MC, Vander Laan B, Maxey B, Cohen I. Cycles of agglutination-disagglutination induced by ristocetin in thrombasthenic platelets. Br J Haematol 1979; 43: 113-126
    CrossrefPubMedGoogle Scholar
  • 16 Joyce RP, Ho FC S, Hui PK, Wong HW, Lai MP. Ristocetin-induced platelet agglutination in four Chinese patients with Glanzmann’s thrombasthenia. Pathology 1985; 17: 71-74
    CrossrefPubMedGoogle Scholar
  • 17 Yoshida E, Fujimura Y, Miura S, Sugimoto M, Fukui H, Narita N, Usami Y, Suzuki M, Titani K. Alboaggregin-B and botrocetin, two snake venom proteins with highly homologous amino acid sequences but totally distinct functions on von Willebrand factor binding to platelets. Biochem Biophys Res Commun 1993; 191: 1386-1392
    CrossrefPubMedGoogle Scholar
  • 18 Jandrot-Perrus M, Huisse M-G, Temisien C, Bezeaud A, Guillin M-C. Thrombin binding to platelet membrane glycoprotein lb. Semin Thromb Hemost 1992; 18: 261-266
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 De Marco L, Mazzucato M, Masotti A, Ruggeri ZM. Localization and characterization of an oc-thrombin-binding site on platelet glycoprotein Iba. J Biol Chem 1994; 269: 6478-6484
    PubMedGoogle Scholar
  • 20 Gralnick HR, Williams S, McKeown LP, Hansmann K, Fenton JW II, Krutzsch H. High-affinity a-thrombin binding to platelet glycoprotein Iba: Identification of two binding domains. Proc Natl Acad Sci USA 1994; 91: 6334-6338
    CrossrefPubMedGoogle Scholar
  • 21 Dong J, Li CQ, Lopez JA. Tyrosine sulfation of the glycoprotein Ib-IX complex: Identification of sulfated residues and effect on ligand binding. Biochemistry 1994; 33: 13946-13953
    CrossrefPubMedGoogle Scholar
  • 22 Haimon JT, Jamieson GA. Platelet activation by thrombin in the absence of the high-affinity thrombin receptor. Biochemistry 1988; 27: 2151-2157
    CrossrefPubMedGoogle Scholar
  • 23 Sims PJ, Ginsberg MH, Plow EF, Shattil SJ. Effect of platelet activation on the conformation of the plasma membrane glycoprotein Ilb-IIIa complex. J Biol Chem 1991; 266: 7345-7352
    PubMedGoogle Scholar
  • 24 Kieffer N, Guichard J, Breton-Gorius J. Dynamic redistribution of major platelet surface receptors after contact-induced platelet activation and spreading: An immunoelectron microscopy study. Am J Pathol 1992; 140: 57-73
    PubMedGoogle Scholar
  • 25 Luscher EF, Weber S. The formation of the haemostatic plug-A special case of platelet aggregation. Thromb Haemost 1993; 70: 234-237
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 O’Toole TE, Katagiri Y, Faull RJ, Peter K, Tamura R, Quaranta V, Loftus JC, Shattil SJ, Ginsberg MH. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 1994; 124: 1047-1059
    CrossrefPubMedGoogle Scholar
  • 27 Frelinger AL III, Du X, Plow EF, Ginsberg MH. Monoclonal antibodies to ligand-occupied conformers of integrin (glycoprotein Ilb-IIIa) alter receptor affinity, specificity, and function. J Biol Chem 1991; 266: 17106-17111
    PubMedGoogle Scholar
  • 28 Hillery CA, Smyth SS, Parise LV. Phosphorylation of human platelet glycoprotein Ilia (GPIIIa). J Biol Chem 1991; 266: 14663-14669
    PubMedGoogle Scholar
  • 29 Elmore MA, Anand R, Horvath AR, Kellie S. Tyrosine-specific phosphorylation of gpllla in platelet membranes. FEBS Lett 1990; 269: 283-287
    CrossrefPubMedGoogle Scholar
  • 30 Nishikawa M, Toyoda H, Saito M, Morita K, Tawara I, Deguchi K, Kuno T, Shima H, Nagao M, Shirakawa S. Calyculin A and okadaic acid inhibit human platelet aggregation by blocking protein phosphatases types 1 and 2A. Cell Signal 1994; 6: 59-71
    CrossrefPubMedGoogle Scholar
  • 31 Isenberg WM, McEver RP, Phillips DR, Shuman MA, Bainton DF. The platelet fibrinogen receptor: An immunogold-surface replica study of agonist-induced ligand binding and receptor clustering. J Cell Biol 1987; 104: 1655-1663
    CrossrefPubMedGoogle Scholar
  • 32 Horvath AR, Muszbek L, Kellie S. Translocation of pp60c-src to the cytoskeleton during platelet aggregation. EMBO J 1992; 11: 855-861
    PubMedGoogle Scholar
  • 33 Chen H-C, Guan J-L. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 1994; 91: 10148-10152
    CrossrefPubMedGoogle Scholar
  • 34 Arcaro A, Wymann MP. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: The role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem J 1993; 296: 297-301
    CrossrefPubMedGoogle Scholar
  • 35 Clemetson KJ, Kehrel B, Kardoeus J, Kronenberg A, von Tschamer V. Myosin light chain kinase inhibitors block platelet aggregation after fibrinogen binding to GPlIb/lIIa. Thromb Haemost 1993; 69: 1023-1023
    PubMedGoogle Scholar
  • 36 Toker A, Meyer M, Reddy KK, Falck JR, Aneja R, Aneja S, Parra A, Bums DJ, Balias LM, Cantley LC. Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3 . J Biol Chem 1994; 269: 32358-32367
    PubMedGoogle Scholar
  • 37 Fox JE B, Lipfert L, Clark EA, Reynolds CC, Austin CD, Brugge JS. On the role of the platelet membrane skeleton in mediating signal transduction. Association of GP Ilb-IIIa, pp60c-src, pp62c-yes, and the p21ras GTPase-activating protein with the membrane skeleton. J Biol Chem 1993; 268: 25973-25984
    PubMedGoogle Scholar
  • 38 Santoro SA, Walsh JJ, Staatz WD, Baranski KJ. Distinct determinants on collagen support a2pt integrin-mediated platelet adhesion and platelet activation. Cell Regul 1991; 2: 905-913
    CrossrefPubMedGoogle Scholar
  • 39 Haimovich B, Lipfert L, Brugge JS, Shattil SJ. Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands. J Biol Chem 1993; 268: 15868-15877
    PubMedGoogle Scholar
  • 40 Morton LF, McCulloch IY, Barnes MJ. Platelet aggregation by a collagenlike synthetic peptide. Thromb Res 1993; 72: 367-372
    CrossrefPubMedGoogle Scholar
  • 41 Kapron-Bras C, Fitz-Gibbon L, Jeevaratnam P, Wilkins J, Dedhar S. Stimulation of tyrosine phosphorylation and accumulation of GTP-bound p21 ras upon antibody-mediated A2B1 integrin activation in T-lymphoblastic cells. J Biol Chem 1993; 268: 20701-20704
    PubMedGoogle Scholar
  • 42 Vuori K, Ruoslahti E. Activation of protein kinase C precedes a5pj integrin-mediated cell spreading on fibronectin. J Biol Chem 1993; 268: 21459-21462
    PubMedGoogle Scholar
  • 43 Hogervorst F, Kuikman I, Noteboom E, Sonnenberg A. The role of phosphorylation in activation of the A6AB1 laminin receptor. J Biol Chem 1993; 268: 18427-18430
    PubMedGoogle Scholar
  • 44 Klemke RL, Yebra M, Bayna EM, Cheresh DA. Receptor tyrosine kinase signaling required for integrin ocvp5-directed cell motility but not adhesion on vitronectin. J Cell Biol 1994; 127: 859-866
    CrossrefPubMedGoogle Scholar
  • 45 Daniel JL, Dangelmaier C, Smith JB. Evidence for a role for tyrosine phosphorylation of phospholipase Cy2 in collagen-induced platelet cytosolic calcium mobilization. Biochem J 1994; 302: 617-622
    CrossrefPubMedGoogle Scholar
  • 46 Tandon NN, Kralisz U, Jamieson GA. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 1989; 264: 7576-7583
    PubMedGoogle Scholar
  • 47 Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD 36 A review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992; 80: 1105-1115
    PubMedGoogle Scholar
  • 48 Goldberger J, Pernambuco M. Analysis of CD36 binding domains: Ligand specificity controlled by dephosphorylation of an ectodomain. Science 1993; 262: 1436-1440
    CrossrefPubMedGoogle Scholar
  • 49 Kehrel B, Kronenberg A, Rauterberg J, Niesing-Bresch D, Niehues U, Kardoeus J, Schwippert B, Tschope D, van de Loo J, Clemetson KJ. Platelets deficient in glycoprotein Illb aggregate normally to collagens type I and III but not to collagen type V. Blood 1993; 82: 3364-3370
    PubMedGoogle Scholar
  • 50 Huang M-M, Bolen JB, Barnwell JW, Shattil SJ, Brugge JS. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc Natl Acad Sci USA 1991; 88: 7844-7848
    CrossrefPubMedGoogle Scholar
  • 51 Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 1989; 84: 1440-1445
    CrossrefPubMedGoogle Scholar
  • 52 Arai M, Yamamoto N, Moroi M, Akamatsu N, Fukutake K, Tanoue K. Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency. Br J Haematol 1995; 89: 124-130
    CrossrefPubMedGoogle Scholar
  • 53 Sugiyama TM, Okuma F, Shinmyozu K. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood 1987; 69: 1712-1720
    PubMedGoogle Scholar
  • 54 Molino M, Di Lallo M, de Gaetano G, Cerletti C. Intracellular Ca2+ rise in human platelets induced by polymorphonuclear-leucocyte-derived cathepsin G. Biochem J 1992; 288: 741-745
    CrossrefPubMedGoogle Scholar
  • 55 Selak MA. Cathepsin G and thrombin: Evidence for two different platelet receptors. Biochem J 1994; 297: 269-275
    CrossrefPubMedGoogle Scholar
  • 56 Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannucci PM. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 1992; 80: 2787-2796
    PubMedGoogle Scholar
  • 57 Gachet C, Cazenave J-P, Ohlmann P, Hilf G, Wieland T, Jakobs KH. ADP receptor-induced activation of guanine-nucleotide-binding proteins inhuman platelet membranes. Eur J Biochem 1992; 207: 259-263
    CrossrefPubMedGoogle Scholar